Alnylam’s Yvonne Greenstreet on RNAi and a ‘golden era’ in biotech
Talks at GS
00:00
Intro
This chapter explores the groundbreaking potential of RNA interference therapeutics in targeting the entire genome, distinguishing it from traditional treatments. The discussion also highlights innovative biotechnology advancements and shares personal insights from leaders in the biopharma industry.
Transcript
Play full episode
